L'Oréal's Dermocosmetics Division Surpasses $1B
L'Oréal's dermocosmetics division has surpassed $1 billion in revenue, becoming a primary profit engine for the beauty conglomerate. The company is also undergoing a leadership overhaul to prioritize digital growth and maintaining investments in sustainability. This strategic shift emphasizes science-backed skincare, which is now reportedly outpacing traditional luxury and mass-market beauty segments.
- The division, officially rebranded from "Active Cosmetics" to "L'Oréal Dermatological Beauty" in early 2023, includes key brands La Roche-Posay, CeraVe, Vichy, SkinCeuticals, and the recently acquired Skinbetter Science. - For the full year 2023, the Dermatological Beauty division reported spectacular like-for-like growth of 28.4%, growing at twice the rate of the dynamic dermocosmetics market. This momentum continued into the first quarter of 2024, with the division's organic sales increasing by 21.9% to €2 billion. - The division's portfolio was expanded with the acquisition of Skinbetter Science in late 2022, a physician-dispensed skincare brand that had recorded nearly USD 95 million in sales in the twelve months prior to the acquisition. - Myriam Cohen-Welgryn has served as the President of the division since early 2021. The broader company is preparing for a leadership transition effective January 1, 2026, which will see David Greenberg become Chairman of L'Oréal USA and Alexis Perakis-Valat appointed CEO of L'Oréal USA and President of North America. - L'Oréal's sustainability efforts are structured under its "L'Oréal for the Future" program, which includes a €100 million Sustainable Innovation Accelerator to fund technologies that lower the environmental impact of its products. - The company has also established a €50 million "Climate Fund for Nature" for carbon offset projects and a separate €15 million "Climate Emergency Fund" to help vulnerable communities impacted by climate disasters. - Growth in Europe and North America, with sales up 12.6% and 12.3% respectively in Q1 2024, has been crucial in offsetting a sales contraction in North Asia, which has been impacted by a gradual market recovery and changes to travel retail regulations in China. - To further its commitment to the sector, L'Oréal launched "L'Oréal Act for Dermatology" in 2024, a five-year, €20-million investment program aimed at improving access to skin health knowledge and care worldwide.
